Biogen Announces Halt to Aduhelm Sales and Development
Cambridge, Massachusetts-based pharmaceutical company Biogen has made a significant decision regarding its Alzheimer's drug, Aduhelm. The drug, once hailed as a potential blockbuster, is...
Tech CEOs Face Congressional Scrutiny over Child Safety Concerns on Social Media
Prominent tech CEOs, including Mark Zuckerberg of Meta, are once again finding themselves under the microscope as Congress investigates the potential risks posed to...
Thriving Real Estate Stocks Thrive Amidst Record-Breaking S&P 500 Highs
With the S&P 500 recently achieving record levels, investors searching for promising opportunities for their retirement accounts face a unique challenge. Yet, in the...
Iran Successfully Launches Three Satellites Amidst Rising Tensions
Iran achieved a significant milestone on Sunday by successfully launching three satellites into space. These launches come despite multiple setbacks in the past and...
New Requirement for AI Companies: Reporting Safety Tests to US Government
In a move to enhance transparency and safety in the rapidly evolving field of artificial intelligence (AI), the Biden administration has initiated a requirement...
Uncomplicated Investments: McDonald’s, Electronic Arts, and Ulta Beauty
Investing in stocks doesn't have to be complicated or dependent on chasing the latest technological trends. Sometimes, the best investment opportunities can be found...